Breaking News Instant updates and real-time market news.

NKTR

Nektar

$53.91

0.45 (0.84%)

10:02
06/14/18
06/14
10:02
06/14/18
10:02

Nektar presents NKTR-181 data showing 'consistently low abuse potential'

Nektar Therapeutics announced that new clinical and preclinical data for NKTR-181 were presented this week at the 80th Annual Scientific Meeting of the College on Problems of Drug Dependence in San Diego, California. NKTR-181 is a new molecular entity and the first analgesic opioid molecule to exhibit a reduced incidence of specific CNS-mediated side effects, such as euphoria, through the targeted alteration of brain-entry kinetics. "We are privileged that these meaningful new data from our clinical trials, as well as our translational research, were recognized for oral presentation at the prestigious CPDD meeting," said Steve Doberstein, Ph.D., SVP and Chief Research and Development Officer of Nektar Therapeutics. "The data presented show that NKTR-181 demonstrates consistently low abuse potential when we look at a range of measurements used to understand potential abuse liability of investigational medicines including the MADDERS assessment. In addition, we demonstrated in our preclinical research that NKTR-181 has a unique neuropharmacodynamic profile with slow brain uptake and a blunted dopamine response as compared to oxycodone." Nektar recently submitted a New Drug Application for NKTR-181 for the treatment of chronic low back pain in adult patients new to opioid therapy. The NDA is supported by an extensive clinical and nonclinical data package. The clinical data submitted in the NDA comprised 15 studies in 2,234 subjects and includes: a 600-patient efficacy study in patients with chronic low back pain who are new to opioid therapy; a 630-patient long-term 52-week safety study in patients with noncancer pain, who are new to opioid therapy, as well as those who are experienced with opioid therapy; pharmacokinetic/pharmacodynamic studies in over 450 subjects; and two human abuse potential studies evaluating both therapeutic and supratherapeutic doses of NKTR-181 versus an oxycodone control in recreational drug users.

NKTR Nektar
$53.91

0.45 (0.84%)

06/04/18
WBLR
06/04/18
NO CHANGE
WBLR
Outperform
William Blair optimism on NKTR-214 remains unchanged
William Blair analyst Andy Hsieh says his long-term optimism on Nektar Therapeutics' NKTR-214 remains unchanged following this weekend's update. Given the recent epacadostat setback, there has been increasing scrutiny around data generated from single-arm uncontrolled studies from both the medical and investment communities, Hsieh tells investors in a research note. The analyst thinks the new data will not quell the bearish views on NKTR-21 and that investor confusion about the Fleming analysis could further add volatility to today's trading session. He believes the true potential of NKTR-214 might not be fully realized until later this year and keeps an Outperform rating on Nektar.
06/05/18
ADAM
06/05/18
NO CHANGE
Target $94
ADAM
Buy
Nektar data suggests it could play pivotal role in cancer, says Canaccord
Canaccord analyst Arlinda Lee said data for Nektar's NKTR-214+Opdivo continues to show promise and she believes it is indicative of having a central role in cancer therapy with its broad mechanism of expanding and activating T-effector cells and efficacy. She reiterated her Buy rating and $94 price target on Nektar shares, which fell nearly 42% to $52.57 yesterday.
06/11/18
HCWC
06/11/18
DOWNGRADE
Target $54
HCWC
Neutral
Nektar downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay downgraded Nektar Therapeutics to Neutral and cut his price target for the shares to $54 from $97. The stock closed Friday up $1.17 to $54.14. An updated cut of NKTR-214 data presented at an investor conference on June 06, does not assuage fears on the outlook of NKTR-214 in the post ECHO-301, immuno-oncology combination therapy landscape, Chattopadhyay tells investors in a research note. This has been "further punctured by the lack of meaningful updates" in non-small-cell lung carcinoma, the primary driver of NKTR-214's valuation in an environment where competition is better positioned, the analyst contends. Chattopadhyay now has a "less than sanguine read of the emerging data" from Nektar.
06/11/18
06/11/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. SemGroup (SEMG) downgraded to Market Perform from Outperform at Wells Fargo with analyst Michael Blum saying he believes its growth trajectory is mostly reflected in valuation. 2. Host Hotels (HST) and Park Hotels (PK) were downgraded to Sell from Neutral at Goldman Sachs, Host Hotels was also downgraded to In Line from Outperform at Evercore ISI. 3. NXP Semiconductors (NXPI) downgraded to Hold from Buy at SunTrust with analyst William Stein saying the current stock price is above fair value and demands "an explicit view" that the Qualcomm (QCOM) bid will receive approval from China regulators. 4. Nektar (NKTR) downgraded to Neutral from Buy at H.C. Wainwright with analyst Debjit Chattopadhyay saying an updated cut of NKTR-214 data presented at an investor conference on June 06, does not assuage fears on the outlook of NKTR-214 in the post ECHO-301, immuno-oncology combination therapy landscape. 5. DDR Corp. (DDR) downgraded to Underperform from In Line at Evercore ISI. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CARB

Carbonite

$37.90

0.6 (1.61%)

22:09
07/18/18
07/18
22:09
07/18/18
22:09
Syndicate
Carbonite 5.463M share Secondary priced at $37.50 »

The company increased the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 02

    Aug

  • 16

    Aug

  • 19

    Jul

ESTA

Establishment Labs

$0.00

(0.00%)

22:05
07/18/18
07/18
22:05
07/18/18
22:05
Syndicate
Establishment Labs 3.725M share IPO priced at $17.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

TLRY

Tilray

$0.00

(0.00%)

22:04
07/18/18
07/18
22:04
07/18/18
22:04
Syndicate
Tilray 9M share IPO priced at $17.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

JBLU

JetBlue

$19.97

0.44 (2.25%)

, EADSY

Airbus

$0.00

(0.00%)

20:47
07/18/18
07/18
20:47
07/18/18
20:47
Periodicals
JetBlue founder to launch new U.S. low-cost airline, LA Times says »

JetBlue (JBLU) founder…

JBLU

JetBlue

$19.97

0.44 (2.25%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

PTC

PTC

$98.51

-0.4 (-0.40%)

20:28
07/18/18
07/18
20:28
07/18/18
20:28
Recommendations
PTC analyst commentary  »

PTC price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

PM

Philip Morris

$82.16

-0.17 (-0.21%)

, UNP

Union Pacific

$141.26

2.96 (2.14%)

20:25
07/18/18
07/18
20:25
07/18/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PM

Philip Morris

$82.16

-0.17 (-0.21%)

UNP

Union Pacific

$141.26

2.96 (2.14%)

DHR

Danaher

$98.80

-0.78 (-0.78%)

BK

BNY Mellon

$55.64

1.59 (2.94%)

BX

Blackstone

$36.23

0.52 (1.46%)

BBT

BB&T

$52.99

1 (1.92%)

TRV

Travelers

$130.03

1.26 (0.98%)

PPG

PPG

$106.84

1.43 (1.36%)

KEY

KeyCorp

$20.30

0.24 (1.20%)

FITB

Fifth Third

$30.26

0.75 (2.54%)

NUE

Nucor

$65.65

1.045 (1.62%)

GPC

Genuine Parts

$94.64

0.47 (0.50%)

ADS

Alliance Data

$226.51

1.13 (0.50%)

DPZ

Domino's Pizza

$283.74

1.74 (0.62%)

DOV

Dover

$74.21

-0.37 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 08

    Aug

  • 26

    Aug

  • 21

    Sep

  • 05

    Oct

  • 30

    Oct

FFKT

Farmers Capital Bank

$53.50

0.65 (1.23%)

20:23
07/18/18
07/18
20:23
07/18/18
20:23
Earnings
Farmers Capital Bank reports Q2 EPS 83c, consensus 73c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$71.49

0.06 (0.08%)

20:13
07/18/18
07/18
20:13
07/18/18
20:13
Recommendations
Anadarko analyst commentary  »

Anadarko price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

HES

Hess Corp.

$64.14

0.67 (1.06%)

20:00
07/18/18
07/18
20:00
07/18/18
20:00
Recommendations
Hess Corp. analyst commentary at MUFG »

Hess Corp price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

NBL

Noble Energy

$34.34

-0.11 (-0.32%)

19:52
07/18/18
07/18
19:52
07/18/18
19:52
Recommendations
Noble Energy analyst commentary at MUFG »

Noble Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

NDLS

Noodles & Company

$11.80

-0.35 (-2.88%)

, IBM

IBM

$144.44

0.98 (0.68%)

19:08
07/18/18
07/18
19:08
07/18/18
19:08
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

NDLS

Noodles & Company

$11.80

-0.35 (-2.88%)

IBM

IBM

$144.44

0.98 (0.68%)

BHLB

Berkshire Hills Bancorp

$40.80

0.15 (0.37%)

CL

Colgate-Palmolive

$64.81

-0.76 (-1.16%)

EGAN

eGain

$13.15

-0.75 (-5.40%)

EBAY

eBay

$37.95

0.13 (0.34%)

CCK

Crown Holdings

$45.12

-0.265 (-0.58%)

PTC

PTC

$98.51

-0.4 (-0.40%)

AXP

American Express

$102.98

1.84 (1.82%)

URI

United Rentals

$155.14

2.94 (1.93%)

AA

Alcoa

$47.90

-0.105 (-0.22%)

SPWH

Sportsman's Warehouse

$5.23

-0.16 (-2.97%)

RUN

Sunrun

$15.16

-0.02 (-0.13%)

CLX

Clorox

$129.50

-5.5 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 27

    Jul

  • 02

    Aug

  • 06

    Aug

  • 08

    Aug

  • 09

    Aug

  • 19

    Jul

GSBC

Great Southern Bancorp

$58.55

-0.2 (-0.34%)

19:03
07/18/18
07/18
19:03
07/18/18
19:03
Earnings
Great Southern Bancorp reports Q2 EPS 97c, consensus 94c »

Reports Q2 NII $41.2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMAB

OMA Airports

$45.82

-0.48 (-1.04%)

18:40
07/18/18
07/18
18:40
07/18/18
18:40
Hot Stocks
OMA Airports reports Q2 passenger traffic up 9.6% »

OMA generated a 25.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPTN

Optinose

$26.97

0.36 (1.35%)

18:35
07/18/18
07/18
18:35
07/18/18
18:35
Recommendations
Optinose analyst commentary at BMO Capital »

Optinose's Xhance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$31.73

-0.02 (-0.06%)

18:29
07/18/18
07/18
18:29
07/18/18
18:29
Periodicals
DOJ: AT&T-Time Warner ruling ignored 'basic economics,' FT reports »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 09

    Aug

SBGI

Sinclair Broadcast

$27.35

-0.65 (-2.32%)

, TRCO

Tribune Media

$34.09

0.79 (2.37%)

18:26
07/18/18
07/18
18:26
07/18/18
18:26
Hot Stocks
FCC votes unanimously to adopt hearing order on Sinclair-Tribune deal »

This evening, the Federal…

SBGI

Sinclair Broadcast

$27.35

-0.65 (-2.32%)

TRCO

Tribune Media

$34.09

0.79 (2.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 06

    Sep

RUN

Sunrun

$15.16

-0.02 (-0.13%)

, JKS

JinkoSolar

$13.70

-0.1 (-0.72%)

18:25
07/18/18
07/18
18:25
07/18/18
18:25
Downgrade
Sunrun, JinkoSolar, Canadian Solar, Vivint Solar rating change at Goldman Sachs »

Sunrun downgraded to…

RUN

Sunrun

$15.16

-0.02 (-0.13%)

JKS

JinkoSolar

$13.70

-0.1 (-0.72%)

CSIQ

Canadian Solar

$12.83

0.15 (1.18%)

VSLR

Vivint Solar

$5.20

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 09

    Aug

SBGI

Sinclair Broadcast

$27.35

-0.65 (-2.32%)

, TRCO

Tribune Media

$34.09

0.79 (2.37%)

18:25
07/18/18
07/18
18:25
07/18/18
18:25
Periodicals
Breaking Periodicals news story on Sinclair Broadcast, Tribune Media »

FCC votes unanimously to…

SBGI

Sinclair Broadcast

$27.35

-0.65 (-2.32%)

TRCO

Tribune Media

$34.09

0.79 (2.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 06

    Sep

RUN

Sunrun

$15.16

-0.02 (-0.13%)

18:13
07/18/18
07/18
18:13
07/18/18
18:13
Downgrade
Sunrun rating change at Goldman Sachs »

Sunrun downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

UNH

UnitedHealth

$255.43

5.11 (2.04%)

, THC

Tenet

$34.57

-0.37 (-1.06%)

18:09
07/18/18
07/18
18:09
07/18/18
18:09
Periodicals
UnitedHealth among suitors eyeing Tenet's Conifer unit, WSJ reports »

UnitedHealth (UNH) is…

UNH

UnitedHealth

$255.43

5.11 (2.04%)

THC

Tenet

$34.57

-0.37 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

MCD

McDonald's

$157.93

-1.83 (-1.15%)

18:06
07/18/18
07/18
18:06
07/18/18
18:06
Hot Stocks
McDonald's partners with Uber Eats for clothing, accessory offers »

McDonald's is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$144.44

0.98 (0.68%)

17:56
07/18/18
07/18
17:56
07/18/18
17:56
Hot Stocks
IBM says its well in advance of its prior cycle »

Sees continued momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

AXP

American Express

$102.98

1.84 (1.82%)

17:45
07/18/18
07/18
17:45
07/18/18
17:45
Hot Stocks
Breaking Hot Stocks news story on American Express »

American Express says NII…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

CENX

Century Aluminum

$14.90

0.13 (0.88%)

, AA

Alcoa

$47.90

-0.105 (-0.22%)

17:44
07/18/18
07/18
17:44
07/18/18
17:44
Hot Stocks
Century Aluminum falls after peer Alcoa cuts EBITDA view »

Shares of Century…

CENX

Century Aluminum

$14.90

0.13 (0.88%)

AA

Alcoa

$47.90

-0.105 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 01

    Aug

AMZN

Amazon.com

$1,842.36

-1.64 (-0.09%)

, CSCO

Cisco

$42.20

-0.13 (-0.31%)

17:34
07/18/18
07/18
17:34
07/18/18
17:34
Periodicals
Amazon not planning to challenge Cisco with switch sales, MarketWatch says »

An AWS spokeswoman…

AMZN

Amazon.com

$1,842.36

-1.64 (-0.09%)

CSCO

Cisco

$42.20

-0.13 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

  • 08

    Aug

  • 16

    Aug

  • 29

    Aug

  • 04

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.